Biblio Discovery — Demo Discovery Service

8 results for "Slade, Ingrid"

Showing 1–8 · 1.77 seconds · RSS

  1. Journal Article Full text

    Evaluating the Integration of Genomics into Cancer Screening Programmes: Challenges and Opportunities

    Briggs, Sarah; Slade, Ingrid

    Curr Genet Med Rep · 2019 · English · PubMed Central

    PURPOSE OF REVIEW: As the costs of genomic testing have fallen, and our understanding of genetic susceptibility to cancers has grown, there has been increasing interest in incorporating testing for cancer susceptibility genes, and polygenic risk estimates, into population cancer screening. A…

  2. Journal Article Full text

    Genomics education for medical professionals – the current UK landscape

    Slade, Ingrid; Subramanian, Deepak N; Burton, Hilary

    Clin Med (Lond) · 2016 · English · PubMed Central

    Genomics education in the UK is at an early stage of development, and its pace of evolution has lagged behind that of the genomics research upon which it is based. As a result, knowledge of genomics and its applications remains limited among non-specialist clinicians. In this review article, we…

  3. Journal Article Full text

    Rethinking the ethical principles of genomic medicine services

    Johnson, Stephanie B.; Slade, Ingrid; Giubilini, Alberto et al.

    Eur J Hum Genet · 2019 · English · PubMed Central

    Clinical genome and exome sequencing is currently used in only a small fraction of patients, yet large scale genomic initiatives are becoming more embedded in clinical services. This paper examines the ethical principles that should guide regulatory processes regarding consent and data sharing in…

  4. Journal Article Full text

    Understanding and using patient experiences as evidence in healthcare priority setting

    Rand, Leah; Dunn, Michael; Slade, Ingrid et al.

    Cost Eff Resour Alloc · 2019 · English · PubMed Central

    BACKGROUND: In many countries, committees make priority-setting decisions in order to control healthcare costs. These decisions take into account relevant criteria, including clinical effectiveness, cost-effectiveness, and need, and are supported by evidence usually drawn from clinical and economic…

  5. Journal Article Full text

    Development of cancer genetic services in the UK: A national consultation

    Slade, Ingrid; Riddell, Daniel; Turnbull, Clare et al.

    Genome Med · 2015 · English · PubMed Central

    BACKGROUND: Technological advances in DNA sequencing have made gene testing fast and affordable, but there are challenges to the translation of these improvements for patient benefit. The Mainstreaming Cancer Genetics (MCG) programme is exploiting advances in DNA sequencing to develop the…

  6. Journal Article Full text

    A cost analysis of a cancer genetic service model in the UK

    Slade, Ingrid; Hanson, Helen; George, Angela et al.

    J Community Genet · 2016 · English · PubMed Central

    Technological advances in DNA sequencing have made gene testing fast and more affordable. Evidence of effectiveness and cost-effectiveness of genetic service models is essential for the successful translation of sequencing improvements for patient benefit, but remain sparse in the genetics…

  7. Journal Article Full text

    Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients

    George, Angela; Riddell, Daniel; Seal, Sheila et al.

    Sci Rep · 2016 · English · PubMed Central

    Advances in DNA sequencing have made genetic testing fast and affordable, but limitations of testing processes are impeding realisation of patient benefits. Ovarian cancer exemplifies the potential value of genetic testing and the shortcomings of current pathways to access testing. Approximately…

  8. Journal Article Full text

    A genome-wide association study identifies susceptibility loci for Wilms tumor

    Turnbull, Clare; Perdeaux, Elizabeth; Pernet, David et al.

    Nat Genet · 2012 · English · PubMed Central

    Wilms tumor is the most common renal malignancy of childhood. To identify common variants that confer susceptibility to Wilms tumor we conducted a genome-wide association study in 757 cases and 1,879 controls. We evaluated ten SNPs in regions significant at P